Tom3 schreef op 16 april 2021 13:47:
Zou dit de reden van de daling zijn? In de cc gisteren werd de vraag gesteld of de AFM13 mono trial vertraging heeft opgelopen:
(antwoord van Harstrick): Firstly, what Adi mentioned already around cohorts is, the TMF cohort -- we are still in the middle of the pandemic situation, U.S. is getting a little bit better but Europe is still heavily infected. So, as we said already during the interim analysis or around the interim analysis, currently we do not feel comfortable to give a very concrete date in terms of enrollment. Remember, protocol mandated cohort B was on hold while we were conducting the interim analysis; so cohort B has now been reopened. But I think it's too early to assess the full impact, and then make a concrete prediction of the timeline. So, I think if we -- if we have reopened cohort B for a little bit longer time and we have a better grasp on the COVID situation, we should be in a position to give you a more granular answer than we can right now.